TOBIRA THERAPEUTICS INC's ticker is TBRA and the CUSIP is 88883P101. A total of 43 filers reported holding TOBIRA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $1,412,000 | +248.6% | 35,540 | +10.3% | 0.00% | +100.0% |
Q2 2016 | $405,000 | +513.6% | 32,210 | +299.5% | 0.00% | – |
Q1 2016 | $66,000 | -16.5% | 8,063 | +3.2% | 0.00% | – |
Q4 2015 | $79,000 | +6.8% | 7,816 | +1.5% | 0.00% | – |
Q3 2015 | $74,000 | -45.2% | 7,703 | -1.4% | 0.00% | – |
Q2 2015 | $135,000 | – | 7,812 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 589,244 | $5,657,000 | 3.30% |
Novo Holdings A/S | 2,696,405 | $26,047,000 | 2.69% |
BVF INC/IL | 1,175,233 | $11,353,000 | 2.29% |
DAFNA Capital Management LLC | 45,092 | $436,000 | 0.43% |
SPHERA FUNDS MANAGEMENT LTD. | 137,622 | $1,329,000 | 0.17% |
Eidelman Virant Capital | 15,000 | $145,000 | 0.10% |
EverPoint Asset Management, LLC | 340,000 | $3,284,000 | 0.08% |
SABBY MANAGEMENT, LLC | 174,943 | $1,690,000 | 0.07% |
Canaan Partners VII LLC | 23,806 | $230,000 | 0.05% |
Blume Capital Management, Inc. | 3,400 | $33,000 | 0.03% |